Status:
COMPLETED
Natural History Study of Patients With Chronic Myelogenous Leukemia
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Gathering information about patients with chronic myelogenous leukemia may help doctors learn more about the disease and find better methods of treatment and on-going care. PURPOSE: This n...
Detailed Description
OBJECTIVES: * Determine the impact of current procedures for diagnosis, management, and follow-up on disease status of patients with newly diagnosed chronic myelogenous leukemia (CML). * Determine th...
Eligibility Criteria
Inclusion
- Age 18 years and over Diagnosis within one year of enrollment
Exclusion
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00429910
Start Date
February 1 2003
End Date
September 1 2005
Last Update
January 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115